TGFB1 and myasthenia gravis: Higher methylation status (33.98% vs. 19.81%) of the promoter gene, lower Ctla4 mRNA, and increased DNTMs expression were detected in patients with myasthenia gravis (MG), causing a reduction in Tregs-related cytokines (TGF-β and IL-10) [110].